Subtopic Deep Dive
Cognitive Outcomes in Autoimmune Encephalitis Survivors
Research Guide
What is Cognitive Outcomes in Autoimmune Encephalitis Survivors?
Cognitive Outcomes in Autoimmune Encephalitis Survivors refers to the long-term assessment of memory deficits, executive dysfunction, and psychiatric symptoms in patients recovering from antibody-mediated encephalitis such as anti-NMDAR forms.
Studies document persistent cognitive impairments in survivors despite immunotherapy, with deficits in memory and executive function persisting years post-onset (Hughes et al., 2010; Irani et al., 2010). Neuropsychological batteries and neuroimaging reveal synaptic disruption links to these outcomes. Over 20 papers since 2010 address this, building on foundational anti-NMDAR encephalitis research.
Why It Matters
Quantifying cognitive sequelae in autoimmune encephalitis survivors informs rehabilitation protocols and disability advocacy, as memory and executive deficits burden daily function (Irani et al., 2010; Najjar et al., 2013). Lancaster (2016) highlights subacute memory loss as a core feature, guiding early intervention. Abboud et al. (2021) recommend standardized outcome tracking to evaluate treatments like rituximab, impacting policy for long-term care.
Key Research Challenges
Heterogeneous Cognitive Profiles
Survivors show variable memory and executive deficits across anti-NMDAR and LGI1 cases, complicating prognosis (Hughes et al., 2010; Irani et al., 2010). Lack of standardized batteries hinders comparisons. Longitudinal studies are sparse.
Linking Antibodies to Impairments
Antibodies target synaptic proteins, but causal paths to persistent psychiatric outcomes remain unclear (Najjar et al., 2013; Lancaster et al., 2011). Neuroimaging correlates are inconsistent. Animal models like Hughes et al. (2010) need human validation.
Long-term Treatment Efficacy
Early immunotherapy improves acute phases but cognitive recovery varies, with relapses noted (Abboud et al., 2021; Thompson et al., 2017). Metrics for chronic rehab are undefined. Pediatric data like Hacohen et al. (2018) show immunotherapy benefits not fully extended to adults.
Essential Papers
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
Ethan G. Hughes, Xiaoyu Peng, Amy J. Gleichman et al. · 2010 · Journal of Neuroscience · 1.1K citations
We recently described a severe, potentially lethal, but treatment-responsive encephalitis that associates with autoantibodies to the NMDA receptor (NMDAR) and results in behavioral symptoms similar...
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
Sarosh R. Irani, Katarzyna D. Bera, Patrick Waters et al. · 2010 · Brain · 1.0K citations
Antibodies to the N-methyl-d-aspartate subtype of glutamate receptor have been associated with a newly-described encephalopathy that has been mainly identified in young females with ovarian tumours...
Neuroinflammation and psychiatric illness
Souhel Najjar, Daniel M. Pearlman, Kenneth Alper et al. · 2013 · Journal of Neuroinflammation · 714 citations
Multiple lines of evidence support the pathogenic role of neuroinflammation in psychiatric illness. While systemic autoimmune diseases are well-documented causes of neuropsychiatric disorders, syna...
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
Hesham Abboud, John C. Probasco, Sarosh R. Irani et al. · 2021 · Journal of Neurology Neurosurgery & Psychiatry · 468 citations
The objective of this paper is to evaluate available evidence for each step in autoimmune encephalitis management and provide expert opinion when evidence is lacking. The paper approaches autoimmun...
Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management
Michael Bradshaw, Arun Venkatesan · 2016 · Neurotherapeutics · 456 citations
The Diagnosis and Treatment of Autoimmune Encephalitis
Eric Lancaster · 2016 · Journal of Clinical Neurology · 428 citations
Autoimmune encephalitis causes subacute deficits of memory and cognition, often followed by suppressed level of consciousness or coma. A careful history and examination may show early clues to part...
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
Ryo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi et al. · 2017 · Neurology Neuroimmunology & Neuroinflammation · 420 citations
These MOG antibody-positive cases represent unique benign unilateral cortical encephalitis with epileptic seizure. The pathology may be autoimmune, although the findings differ from MOG antibody-as...
Reading Guide
Foundational Papers
Start with Hughes et al. (2010) for synaptic mechanisms and Irani et al. (2010) for clinical progression, as they establish anti-NMDAR cognitive baselines with 1108 and 1006 citations.
Recent Advances
Study Abboud et al. (2021) for management recs and Thompson et al. (2017) for immunotherapy timing impacts on outcomes.
Core Methods
Neuropsychological batteries for memory/executive tests; antibody assays and MRI for correlations (Lancaster, 2016; Najjar et al., 2013).
How PapersFlow Helps You Research Cognitive Outcomes in Autoimmune Encephalitis Survivors
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map 1108-cited Hughes et al. (2010) foundational work to recent Abboud et al. (2021), revealing cognitive outcome clusters. exaSearch uncovers sparse longitudinal studies; findSimilarPapers links Irani et al. (2010) to survivor cohorts.
Analyze & Verify
Analysis Agent employs readPaperContent on Irani et al. (2010) to extract progression data, then runPythonAnalysis for meta-stats on deficit rates across 10 papers. verifyResponse with CoVe flags inconsistencies in antibody-cognition links; GRADE grading scores evidence from Najjar et al. (2013) as moderate for psychiatric ties.
Synthesize & Write
Synthesis Agent detects gaps in long-term rehab data via contradiction flagging between acute (Lancaster, 2016) and chronic outcomes. Writing Agent uses latexEditText, latexSyncCitations for outcome tables, and latexCompile for reports; exportMermaid diagrams antibody-impact pathways.
Use Cases
"Run stats on memory deficit rates in anti-NMDAR survivors from top papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis on Hughes 2010, Irani 2010 data) → CSV export of deficit percentages and p-values.
"Draft LaTeX review on cognitive sequelae post-immunotherapy."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Abboud 2021, Lancaster 2016) → latexCompile → PDF with cited outcome tables.
"Find code for analyzing encephalitis neuroimaging data."
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for MRI-cognition correlation from similar neuroinflammation repos.
Automated Workflows
Deep Research workflow scans 50+ papers via citationGraph from Hughes et al. (2010), producing structured reports on cognitive trajectories with GRADE scores. DeepScan applies 7-step CoVe to verify Najjar et al. (2013) psychiatric claims against survivor data. Theorizer generates hypotheses on synaptic repair from Irani et al. (2010) mechanisms.
Frequently Asked Questions
What defines cognitive outcomes in autoimmune encephalitis survivors?
Persistent memory, executive, and psychiatric deficits post-recovery from anti-NMDAR or LGI1 encephalitis, assessed via batteries (Hughes et al., 2010; Lancaster, 2016).
What methods evaluate these outcomes?
Neuropsychological testing and neuroimaging track deficits; immunotherapy response measured via scales (Abboud et al., 2021; Irani et al., 2010).
What are key papers?
Hughes et al. (2010, 1108 citations) on mechanisms; Irani et al. (2010, 1006 citations) on progression; Najjar et al. (2013) on psychiatric links.
What open problems exist?
Standardized long-term metrics, rehab efficacy predictors, and antibody-specific profiles remain unresolved (Lancaster, 2016; Hacohen et al., 2018).
Research Autoimmune Neurological Disorders and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Cognitive Outcomes in Autoimmune Encephalitis Survivors with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers